QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, January 9, 2008, 28(2):465-472; doi:10.1523/JNEUROSCI.4778-07.2008

This Article Full Text Full Text (PDF) Supplemental Data Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Trinh, K. Articles by Pallanck, L. J. Search for Related Content PubMed PubMed Citation Articles by Trinh, K. Articles by Pallanck, L. J.

 Previous Article  |  Next Article 

Neurobiology of Disease
Induction of the Phase II Detoxification Pathway Suppresses Neuron Loss in Drosophila Models of Parkinson's Disease

Kien Trinh,¹ Katherine Moore,¹ Paul D. Wes,⁴ Paul J. Muchowski,³ Joyoti Dey,² Laurie Andrews,¹ and Leo J. Pallanck¹

¹Department of Genome Sciences and ²Molecular and Cellular Biology Program, University of Washington, Seattle, Washington 98195, ³Gladstone Institute of Neurological Disease and Departments of Biochemistry and Biophysics, and Neurology, University of California, San Francisco, San Francisco, California 94158, ⁴Elan Pharmaceuticals, South San Francisco, California 94080

Correspondence should be addressed to Dr. Leo J. Pallanck, University of Washington, 1705 NE Pacific Street, Foege S-443E, Box 355065, Seattle, WA 98195-5065. Email: pallanck{at}u.washington.edu

-Synuclein aggregates are a common feature of sporadic Parkinson's disease (PD), and mutations that increase -synuclein abundance confer rare heritable forms of PD. Although these findings suggest that -synuclein plays a central role in the pathogenesis of this disorder, little is known of the mechanism by which -synuclein promotes neuron loss or the factors that regulate -synuclein toxicity. To address these matters, we tested candidate modifiers of -synuclein toxicity using a Drosophila model of PD. In the current work, we focused on phase II detoxification enzymes involved in glutathione metabolism. We find that the neuronal death accompanying -synuclein expression in Drosophila is enhanced by loss-of-function mutations in genes that promote glutathione synthesis and glutathione conjugation. This neuronal loss can be overcome by genetic or pharmacological interventions that increase glutathione synthesis or glutathione conjugation activity. Moreover, these same pharmacological agents suppress neuron loss in Drosophila parkin mutants, a loss-of-function model of PD. Our results suggest that oxidative stress is a feature of -synuclein toxicity and that induction of the phase II detoxification pathway represents a potential preventative therapy for PD.

Key words: -synuclein; dopamine; Drosophila; synucleinopathy; glutathione; glutathione S-transferase

---

Received Jan. 22, 2007; accepted Nov. 19, 2007.

Correspondence should be addressed to Dr. Leo J. Pallanck, University of Washington, 1705 NE Pacific Street, Foege S-443E, Box 355065, Seattle, WA 98195-5065. Email: pallanck{at}u.washington.edu

This article has been cited by other articles:

				Weidong Le, Shen Chen, and J. Jankovic Etiopathogenesis of Parkinson Disease: A New Beginning? Neuroscientist, February 1, 2009; 15(1): 28 - 35. [Abstract] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help